AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
GLYCINE
21 registrations across 4 African markets— 13 active
Markets with GLYCINE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| 1.5% GLYCINE IRRIGATION FLUID(INTRAFLEX) INFUSION (Each ml contains Glycine 1.5%w/v) | 🇬🇭Ghana | — | active | Aug 2029 |
| 1.5% GLYCINE IRRIGATION FLUID(INTRAFLEX) INFUSION (Each ml contains Glycine 1.5%w/v) | 🇬🇭Ghana | — | active | Aug 2029 |
| 1.5% GLYCINE IRRIGATION FLUID(INTRAFLEX) INFUSION (Each ml contains Glycine 1.5%w/v) | 🇬🇭Ghana | — | active | Nov 2027 |
| 1.5% GLYCINE IRRIGATION FLUID(INTRAFLEX) INFUSION (Each ml contains Glycine 1.5%w/v) | 🇬🇭Ghana | — | active | Nov 2027 |
| SABAX SYNTHAMIN 14 WITH ELECTROLYTES 8,5% AMINO ACID | 🇿🇦South Africa | Adcock Ingram Critical Care (Pty) Ltd | suspended | Sept 2025 |
| SYNTHAMIN 17 WITHOUT ELECTROLYTES 10% AMINO ACID INJECTION | 🇿🇦South Africa | Adcock Ingram Critical Care (Pty) Ltd | suspended | Sept 2025 |
| SABAX SYNTHAMIN 17 WITH ELECTROLYTES 10% AMINO ACID INJECTION | 🇿🇦South Africa | Adcock Ingram Critical Care (Pty) Ltd | suspended | Sept 2025 |
| SABAX SYNTHAMIN 9 WITH ELECTROLYTES 5,5% AMINO ACIDS | 🇿🇦South Africa | Adcock Ingram Critical Care (Pty) Ltd | suspended | Sept 2025 |
| SYNTHAMIN 9 WITHOUT ELECTROLYTES 5,5% AMINO ACID INJECTION | 🇿🇦South Africa | Adcock Ingram Critical Care (Pty) Ltd | suspended | Sept 2025 |
| AMINOSTERIL KE 10% CARBOHYDRATE FREE | 🇿🇦South Africa | Fresenius Kabi South Africa (Pty) Ltd | suspended | May 2025 |
| VAMIN 14 ELECTROLYTE FREE | 🇿🇦South Africa | Fresenius Kabi South Africa (Pty) Ltd | suspended | May 2025 |
| INTRAMED GLYCINE 1,5% m/v IRRIGATION SOLUTION | 🇿🇦South Africa | Pharmacare Limited û Woodmead | suspended | Nov 2022 |
| VAMINOLACT | 🇿🇦South Africa | Fresenius Kabi South Africa (Pty) Ltd | active | Jan 1900 |
| AMINOVEN INFANT 10 % | 🇿🇦South Africa | Fresenius Kabi South Africa (Pty) Ltd | active | Jan 1900 |
| VAMIN 18 ELECTROLYTE FREE | 🇿🇦South Africa | Fresenius Kabi South Africa (Pty) Ltd | active | Jan 1900 |
| AMINOVEN 15 % | 🇿🇦South Africa | Fresenius Kabi South Africa (Pty) Ltd | active | Jan 1900 |
| AMINOVEN 5 % | 🇿🇦South Africa | Fresenius Kabi South Africa (Pty) Ltd | active | Jan 1900 |
| AMINOVEN 10 % | 🇿🇦South Africa | Fresenius Kabi South Africa (Pty) Ltd | active | Jan 1900 |
| Glycine Capsule | 🇰🇪Kenya | GM MEDICAL & SUPPLIES LTD | active | — |
| HYDRALIN GYN 144 % SOLUTION POUR USAGE EXTERNE FLACON DE 200 ML | 🇨🇮Côte d'Ivoire | BAYER CONSUMER CARE AG | active | — |
| Glycine 1000mg Tablet | 🇰🇪Kenya | Armaan Limited | active | — |
GLYCINE in Africa — Regulatory Overview
GLYCINE is registered across 4 African markets with 21 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa, Ghana, Kenya, Côte d'Ivoire. AfricaRegulatory refreshes this data daily from official government sources.
Of the 21 registrations, 13 (62%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.